Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

por Doshi, Kshama A., Trotta, Rossana, Natarajan, Karthika, Rassool, Feyruz V., Tron, Adriana E., Huszar, Dennis, Perrotti, Danilo, Baer, Maria R.
Publicado 2016

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

por Srutova, Klara, Curik, Nikola, Burda, Pavel, Savvulidi, Filipp, Silvestri, Giovannino, Trotta, Rossana, Klamova, Hana, Pecherkova, Pavla, Sovova, Zofie, Koblihova, Jitka, Stopka, Tomas, Perrotti, Danilo, Polakova, Katerina Machova
Publicado 2018

The PP2A inhibitor SET regulates natural killer cell IFN-γ production

por Trotta, Rossana, Ciarlariello, David, Col, Jessica Dal, Allard, Jeffrey, Neviani, Paolo, Santhanam, Ramasamy, Mao, Hsiaoyin, Becknell, Brian, Yu, Jianhua, Ferketich, Amy K., Thomas, Brittany, Modi, Aalok, Blaser, Bradley W., Perrotti, Danilo, Caligiuri, Michael A.
Publicado 2007

Altered sialidase expression in human myeloid cells undergoing apoptosis and differentiation

por Hyun, Sang W., Feng, Chiguang, Liu, Anguo, Lillehoj, Erik P., Trotta, Rossana, Kingsbury, Tami J., Passaniti, Antonino, Lugkey, Katerina N., Chauhan, Sitara, Cipollo, John F., Luzina, Irina G., Atamas, Sergei P., Cross, Alan S., Goldblum, Simeon E.
Publicado 2022